Meeting
2020 ASCO Virtual Scientific Program
HPV ctDNA analysis in unresectable recurrent/metastatic oropharyngeal cancer.
Authors
Catherine T Haring
University of Michigan Department of Otolaryngology-Head and Neck Surgery, Ann Arbor, MI
Catherine T Haring , Collin Brummel , Brittany Jewell , Molly Heft Neal , Emily Bellile , Matthew E Spector , Michelle Mierzwa , Francis P. Worden , Muneesh Tewari , Chad Brenner , Paul Swiecicki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 6554)
DOI
10.1200/JCO.2020.38.15_suppl.6554
Abstract #
6554
Poster Bd #
215
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal canal carcinoma.
First Author: Luc Cabel
Poster
2017 ASCO Annual Meeting
Predicting response to radical (chemo)radiotherapy (R-CRT) with circulating HPV DNA and tumor DNA (ctDNA) analysis in locally-advanced head and neck squamous cell carcinoma (LAHNC).
First Author: Shreerang Bhide
Poster
2016 ASCO Annual Meeting
Comparison of outcomes following recurrence or metastasis in HPV+ and HPV- oropharyngeal carcinoma treated with definitive chemoradiation using IMRT.
First Author: Jonathan Eric Leeman
Poster
2024 ASCO Annual Meeting
Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial.
First Author: Daniel McGrail